Shotaro Iwamoto

1.8k citations

65 papers · 1.2k indexed · 1 hit paper · h-index 15

Immunology top 5%
- T-cell and B-cell Immunology 13
- Immune Cell Function and Interaction 11
- Immunotherapy and Immune Responses 8
Hematology top 5%
- Hematopoietic Stem Cell Transplantation 19
- Acute Myeloid Leukemia Research 16
Oncology top 5%
Genetics
Molecular Biology
Public Health, Environmental and Occupational Health
- Acute Lymphoblastic Leukemia research 12
Pediatrics, Perinatology and Child Health
- Childhood Cancer Survivors' Quality of Life 5
Neurology
- Neuroblastoma Research and Treatments 5

Co-authors: Dario Campana Chihaya Imai Yoshihiro Komada Eiichi Azuma Masahiro Hirayama Tadashi Kumamoto Michihiro Kobayashi Masaru Ido
Cited by: Immunology Hematology Oncology
Partner nations: Japan United States Sweden

In The Last Decade

Shotaro Iwamoto

58 papers receiving 1.1k citations

Hit Papers

align trajectories log scale

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

2005 Genetic modification of primary natural killer cells overcomes inhibitory signals and induces specific killing of leukemic cells

Peers

Countries citing papers authored by Shotaro Iwamoto

Since Specialization

Citations

This map shows the geographic impact of Shotaro Iwamoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shotaro Iwamoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shotaro Iwamoto more than expected).

Fields of papers citing papers by Shotaro Iwamoto

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shotaro Iwamoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shotaro Iwamoto. The network helps show where Shotaro Iwamoto may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Shotaro Iwamoto, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Shotaro Iwamoto Line = papers co-authored together Shotaro Iwamoto links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Secondary neoplasms in survivors of pediatric acute lymphoblastic leukemia and lymphoblastic lymphoma: a single-center, retrospective study Eri Ushida,Hidemi Toyoda,Atsushi Kohso,Yasuyuki Okumura,Kaori Niwa,Takahiro Ito,Mari Morimoto,Ryo Hanaki,Keishiro Amano,Shotaro Iwamoto,Takao Deguchi,Hiroki Hori,Masahiro Hirayama	2025	0
2	Analysis of overweight/obese pediatric patients with acute myeloid leukemia: a report from the Japanese Pediatric Leukemia/Lymphoma Study Group AML-05 study Hirozumi Sano,Keitaro Fukushima,Michihiro Yano,Shinya Osone,Yoko Kato,Daiichiro Hasegawa,Takako Miyamura,Shotaro Iwamoto,Hiroyuki Takahashi,Kiminori Terui,Akio Tawa,Daisuke Tomizawa	2024	0
3	Adverse prognostic impact of <i>KIT</i> exon 17 mutations despite negative flow cytometric measurable residual disease in pediatric acute myeloid leukemia with <i>RUNX1::RUNX1T1</i> Shota Kato,Shin‐ichi Tsujimoto,Jun Matsubayashi,Shotaro Iwamoto,Hidefumi Hiramatsu,Yusuke Okuno,Tatsuya Kamitori,Kentaro Ohki,Takao Deguchi,Nobutaka Kiyokawa,Motohiro Kato,Junko Takita,Shiro Tanaka,Souichi Adachi,Daisuke Tomizawa,Norio Shiba	2024	0
4	Improved Antitumor Effect of NK Cells Activated by Neutrophils in a Bone Marrow Transplant Model Daisuke Nakato,Shotaro Iwamoto,Keishiro Amano,Takahiro Ito,Hidemi Toyoda,Ryo Hanaki,Mari Morimoto,Kaori Niwa,Isao Tawara,Kyoko Imanaka-Yoshida,Masahiro Ogawa,Masahiro Hirayama	2023	1
5	High IL2RA/CD25 expression is a prognostic stem cell biomarker for pediatric acute myeloid leukemia without a core‐binding factor Takahiro Aoki,Norio Shiba,Shin‐ichi Tsujimoto,Genki Yamato,Yusuke Hara,Shota Kato,Kenichi Yoshida,Seishi Ogawa,Yasuhide Hayashi,Shotaro Iwamoto,Tomohiko Taki,Akira Shimada,Yuka Iijima‐Yamashita,Keizo Horibe,Akio Tawa,Takashi Taga,Souichi Adachi,Daisuke Tomizawa	2023	5
6	Challenges to Widespread Use of Fertility Preservation Facilities for Pediatric Cancer Patients in Japan Tadashi Maezawa,Nao Suzuki,Hiroki Takeuchi,Mikiko Nishioka,Moe Hidaka,Atsushi Manabe,Yuhki Koga,Hiroshi Kawaguchi,Yoji Sasahara,Masahito Tachibana,Shotaro Iwamoto,Akihito Horie,Hidefumi Hiramatsu,Motohiro Kato,Miyuki Harada,Yuki Yuza,Masahiro Hirayama,Junko Takita,Tomoaki Ikeda,Kimikazu Matsumoto	2023	0
7	Donor‐derived M2 macrophages attenuate GVHD after allogeneic hematopoietic stem cell transplantation Ryo Hanaki,Hidemi Toyoda,Shotaro Iwamoto,Mari Morimoto,Daisuke Nakato,Takahiro Ito,Kaori Niwa,Keishiro Amano,Ryotaro Hashizume,Isao Tawara,Masahiro Hirayama	2021	12
8	Transient hypogammaglobulinemia of infancy may be associated with reduced switched memory B cells and del (16) (p11.2p12) Tsuyoshi Ito,Shotaro Iwamoto,Masahiro Hirayama,Yasuharu Yamada,Eiichi Azuma	2021	1
9	The outcomes of relapsed acute myeloid leukemia in children: Results from the Japanese Pediatric Leukemia/Lymphoma Study Group AML‐05R study Hiroshi Moritake,Shiro Tanaka,Takako Miyamura,Hideki Nakayama,Norio Shiba,Akira Shimada,Kiminori Terui,Yuki Yuza,Katsuyoshi Koh,Hiroaki Goto,Harumi Kakuda,Akiko Saito,Daisuke Hasegawa,Shotaro Iwamoto,Takashi Taga,Souichi Adachi,Daisuke Tomizawa	2020	12
10	Reliability and validity of the Japanese version of the Paediatric Pain Profile for children with severe motor and intellectual disabilities Mayumi Okita,Nio Kaori,Mayumi Murabata,Hiroaki Murata,Shotaro Iwamoto	2020	3
11	Characteristics and outcomes of children with acute myeloid leukemia and Down syndrome who are ineligible for clinical trials due to severe comorbidities Kentaro Nakashima,Daisuke Hasegawa,Daisuke Tomizawa,Takako Miyamura,Asahito Hama,Shotaro Iwamoto,Kiminori Terui,Souichi Adachi,Takashi Taga	2019	1
12	Clinical and biological features of paediatric acute myeloid leukaemia (AML) with primary induction failure in the Japanese Paediatric Leukaemia/Lymphoma Study Group AML‐05 study Takako Miyamura,Hiroshi Moritake,Hideki Nakayama,Shiro Tanaka,Daisuke Tomizawa,Norio Shiba,Akiko Saito,Akio Tawa,Akira Shimada,Shotaro Iwamoto,Yasuhide Hayashi,Takashi Koike,Keizo Horibe,Atsushi Manabe,Shuki Mizutani,Takashi Taga,Souichi Adachi	2019	15
13	Induction of MEK/ERK activity by AZD8055 confers acquired resistance in neuroblastoma Dongqing Xu,Hidemi Toyoda,Qi Lei,Mari Morimoto,Ryo Hanaki,Shotaro Iwamoto,Yoshihiro Komada,Masahiro Hirayama	2018	14
14	Fludarabine, cytarabine, granulocyte colony‐stimulating factor and idarubicin for relapsed childhood acute myeloid leukemia Hideki Nakayama,Daisuke Tomizawa,Shiro Tanaka,Shotaro Iwamoto,Akira Shimada,Akiko Saito,Yuka Yamashita,Hiroshi Moritake,Kiminori Terui,Takashi Taga,H. Matsuo,Yoshiyuki Kosaka,Katsuyoshi Koh,Hajime Hosoi,Hidemitsu Kurosawa,Keiichi Isoyama,Keizo Horibe,Shuki Mizutani,Souichi Adachi	2017	6
15	Mesenchymal Stromal Cell Secretome Up-Regulates 47 kDa CXCR4 Expression, and Induce Invasiveness in Neuroblastoma Cell Lines Vipin Shankar,Hiroki Hori,Kentaro Kihira,Qi Lei,Hidemi Toyoda,Shotaro Iwamoto,Yoshihiro Komada	2015	17
16	Simultaneous occurrence of gastric antral vascular ectasia and protein-losing enteropathy in chronic graft-versus-host disease Masahiro Hirayama,Eiichi Azuma,Atsuko Nakazawa,Shotaro Iwamoto,Hidemi Toyoda,Yoshihiro Komada	2013	3
17	Wheat-dependent exercise-induced anaphylaxis associated with a facial soap Shotaro Iwamoto,Noboru Hagino,Tetsuya Tanimoto,Eiji Kusumi	2012	4
18	Flow cytometric analysis of de novo acute lymphoblastic leukemia in childhood: report from the Japanese Pediatric Leukemia/Lymphoma Study Group Shotaro Iwamoto,Takao Deguchi,Hideaki Ohta,Nobutaka Kiyokawa,Masahito Tsurusawa,Tomomi Yamada,Kozo Takase,Junichiro Fujimoto,Ryoji Hanada,Hiroki Hori,Keizo Horibe,Yoshihiro Komada	2011	26
19	BK VIRUS-ASSOCIATED FATAL RENAL FAILURE FOLLOWING LATE-ONSET HEMORRHAGIC CYSTITIS IN AN UNRELATED BONE MARROW TRANSPLANTATION Shotaro Iwamoto,Eiichi Azuma,Hiroki Hori,Masahiro Hirayama,Michihiro Kobayashi,Yoshihiro Komada,Hisashi Nishimori,Masazumi Miyahara,Yoshiya Nishide	2002	36
20	A Pivotal Role of Rho GTPase in the Regulation of Morphology and Function of Dendritic Cells Michihiro Kobayashi,Eiichi Azuma,Masaru Ido,Masahiro Hirayama,Qi Jiang,Shotaro Iwamoto,Tadashi Kumamoto,Hatsumi Yamamoto,Minoru Sakurai,Yoshihiro Komada	2001	67

About Shotaro Iwamoto

Shotaro Iwamoto is a scholar working on Hematology, Immunology and Public Health, Environmental and Occupational Health, having authored 65 papers that have together received 1.2k indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (19 papers), Acute Myeloid Leukemia Research (16 papers), T-cell and B-cell Immunology (13 papers), Acute Lymphoblastic Leukemia research (12 papers), Immune Cell Function and Interaction (11 papers), Immunotherapy and Immune Responses (8 papers), Childhood Cancer Survivors' Quality of Life (5 papers) and Neuroblastoma Research and Treatments (5 papers). The work is most often cited by research in Immunology (680 citations), Hematology (294 citations) and Oncology (508 citations). Shotaro Iwamoto has collaborated with scholars based in Japan, United States and Sweden. Frequent co-authors include Dario Campana, Chihaya Imai, Yoshihiro Komada, Eiichi Azuma, Masahiro Hirayama, Tadashi Kumamoto, Michihiro Kobayashi, Masaru Ido, Hidemi Toyoda and Hiroki Hori.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact